Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ludwig Enterprises's Enterprise Value is $21.34 Mil.
Ludwig Enterprises's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $-2.98 Mil. Therefore, Ludwig Enterprises's EV-to-EBIT ratio for today is -7.16.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ludwig Enterprises's Enterprise Value is $21.34 Mil.
Ludwig Enterprises's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was $-2.98 Mil. Therefore, Ludwig Enterprises's EV-to-EBITDA ratio for today is -7.16.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ludwig Enterprises's Enterprise Value is $21.34 Mil.
Ludwig Enterprises's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00 Mil. Therefore, Ludwig Enterprises's EV-to-Revenue ratio for today is .
Ludwig Enterprises Enterprise Value Historical Data
The historical data trend for Ludwig Enterprises's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ludwig Enterprises's Enterprise Value
For the Medical Devices subindustry, Ludwig Enterprises's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ludwig Enterprises's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ludwig Enterprises's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Ludwig Enterprises's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Ludwig Enterprises's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ludwig Enterprises (OTCPK:LUDG) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Ludwig Enterprises's current Enterprise Value is $21.34 Mil.
Ludwig Enterprises's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.98 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Ludwig Enterprises's current Enterprise Value is $21.34 Mil.
Ludwig Enterprises's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.98 Mil.
Ludwig Enterprises's current Enterprise Value is $21.34 Mil.
Ludwig Enterprises's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
Ludwig Enterprises's current Enterprise Value is $21.34 Mil.
Ludwig Enterprises's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ludwig Enterprises Enterprise Value Related Terms
Thank you for viewing the detailed overview of Ludwig Enterprises's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LUDG has been successfully added to your 